Measures of hospital operation and patient treatment management under the epidemic of coronavirus disease 2019 in tuberculosis hospital

doi:10.3969/j.issn.1000-6621.2020.04.019

Abstract

Abstract:

After the outbreak of coronavirus disease 2019 (COVID-19), how to carry out medical treatment and management of patients with tuberculosis has become a new issue and challenge. As a designated medical institution of COVID-19 in Shaanxi Province and Xi’an City, Xi’an Chest Hospital has successfully completed the treatment and management of patients with tuberculosis through seven comprehensive measures during the epidemic period. This paper provides management ideas for other tuberculosis prevention and control institutions.

Key words: Coronavirus disease 2019 (COVID-19), Disease outbreaks, Tuberculosis, Hospitals,special, Practice management,medical, Problem-based learning

REN Fei,ZHANG Meng-tao,DANG Li-yun. Measures of hospital operation and patient treatment management under the epidemic of coronavirus disease 2019 in tuberculosis hospital[J]. Chinese Journal of Antituberculosis, 2020, 42(4): 404-405. doi: 10.3969/j.issn.1000-6621.2020.04.019

References 7

[1]	中华人民共和国国家卫生健康委员会办公厅, 中华人民共和国国家中医药管理局办公室. 关于印发新型冠状病毒肺炎诊疗方案(试行第六版)的通知[EB/OL]. 国卫办医函〔2020〕145号. 2020- 02- 18.[2020-03-05].http://www.gov.cn/zhengce/zhengceku/2020-02/19/content_5480948.htm.
[2]	中华医学会急诊医学分会感染学组, 中国医学协会急诊医师分会感染学组, 首都医科大学急诊医学学系. 可疑呼吸道传染性疾病急诊医学科应对方案 [J/OL]. 中华急诊医学杂志,2020,29. 2020- 02- 02. [2020-03-05]. http://rs.yiigle.com/yufabiao/1179571.htm.
[3]	中华人民共和国国家卫生健康委员会办公厅. 医疗机构内新型冠状病毒感染预防与控制技术指南(第一版)[EB/OL]. 国卫办医函〔2020〕65 号. 2020- 01- 23. [2020-03-05]. http://www.nhc.gov.cn/xcs/yqfkdt/202001/b91fdab7c304431eb082 d67847d27e14.shtml.
[4]	陈晓凤, 王秀华, 聂菲菲 . 肺结核患者关怀与支持干预研究进展. 中国防痨杂志, 2019,41(7):775-778.
[5]	中华医学会结核病学分会重症专业委员会. 结核病营养治疗专家共识. 中华结核和呼吸杂志, 2020,43(1):17-26.
[6]	蔡欢乐, 朱言欣, 雷璐碧 , 等. 新型冠状病毒肺炎相关知识、行为和心理应对:基于网络的横断面调查[J/OL]. 中国公共卫生,2020. 2020- 02- 26. [2020-03-05].http://www.zgggws.com/cn/article/doi/10.11847/zgggws1128106 .
[7]	中华人民共和国国家卫生健康委员会, 中华人民共和国国家中医药管理局. 关于印发互联网诊疗管理办法(试行)等3个文件的通知[EB/OL]. 国卫医发〔2018〕25号. 2018- 07- 17. [2020-03-05]. http://www.gov.cn/zhengce/zhengceku/2018-12/31/content_5435436.htm.

[1]	LIU Xiao-li, LEI Li-mei, GUO Zhou-li, HUANG Yin, XU Jing, ZHAO Xia, WANG Yan, FU Li. Study on the relationship of stigma and social support of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 1002-1008.
[2]	Academic Working Committee of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis . Expert consensus of clinical application of fixed-dose combination formulations [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 885-893.
[3]	JIN Hong-jian. The construction of tuberculosis prevention and control service system at county level in China needs to be strengthened urgently —— Comments and suggestions of an old tuberculosis control and prevention worker [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 896-902.
[4]	ZHANG Can-you, XIA Hui, CHENG Jun. Testing and reporting requirements for Class Ⅱ biosafety cabinet in tuberculosis laboratory [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 903-909.
[5]	ZHOU Lin, LIU Er-yong, MENG Qing-lin, CHEN Ming-ting, ZHOU Xin-hua, GAO Wei-wei, LIN Ming-gui, XIE Ru-ming. Evaluation of the quality of pulmonary tuberculosis diagnosis after the implementation of the newly revised WS 288-2017 Diagnosis for pulmonary tuberculosis standards [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 910-915.
[6]	LIU Er-yong, WANG Qian, ZHOU Lin, ZHANG Guo-qin, ZHANG Xiu-lei, MA Yong-cheng, YANG Shu-min, WANG Cui, MENG Qing-lin, CHEN Ming-ting, LIN Ming-gui, TU De-hua.. Analysis of diagnostic quality of pulmonary tuberculosis with negative etiology in some areas of China [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 916-920.
[7]	MENG Qing-lin, LI Jin-lan, LIN Ding-wen, MA Yong-cheng, HOU Shuang-yi, LIU Nian-qiang, ZHOU Lin. Analysis of the awareness about knowledge on the updated TB diagnosis standard among the practitioners in TB control institutions [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 921-925.
[8]	WANG Qian, ZHOU Lin, LIU Er-yong, ZHAO Yan-lin, LI Tao, CHEN Ming-ting, YANG Li-jia, WANG Jia.. A survey on the diagnostic ability of tuberculosis in the county-level medical institutions in China [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 926-930.
[9]	LI Ting, HE Jin-ge, SU Qian, LI Jing, LI Yun-kui, GAO Wen-feng, GAO Yuan, YANG Wen. Value of tuberculin test in screening tuberculosis infection in HIV infected/AIDS patients in Butuo County, Sichuan Province [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 931-936.
[10]	LI Yun-kui, HE Jin-ge, SU Qian, LI Ting, LI Jing, GAO Wen-feng, YANG Wen, MAO Guang-yu. Value of tuberculin test in screening tuberculosis infection in HIV infected/AIDS patients in Butuo County, Sichuan Province [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 937-941.
[11]	SU Qian, XIA Yong, LU Jia, WANG Dan-xia, HE Jin-ge. Analysis on the epidemiological characteristics of pulmonary tuberculosis among children aged 0-14 in Sichuan Province from 2009 to 2018 [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 942-947.
[12]	DENG Ya-li, ZHANG Tian-hua, LIU Wei-ping, ZHANG Hong-wei, MA Yu, LI Peng.. Temporal and spatial clustering analysis of pulmonary tuberculosis incidence in Shaanxi Province from 2014 to 2018 [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 948-955.
[13]	DONG Xiao, ZHAO Zhen, LIU Nian-qiang, WANG Sen-lu, CUI Yan. Analysis of the finding characteristics of pulmonary tuberculosis in the elderly population in Xinjiang Uygur Autonomous Region during 2009—2017 [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 956-961.
[14]	MA Ting-long, HAN Yi, CHENG Xu, LIU Zhi-dong. Clinical observation on treatment effectiveness of transdermal ultrasound-mediated drug delivery combined with oral anti-tuberculosis drug in patients with chest wall tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 968-972.
[15]	NAN Hai, ZHANG Yun, YANG Xin-ting, DUAN Hong-fei. Meta-analysis on the diagnostic value of GeneXpert MTB/RIF for bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 973-980.